Knee registry for patients receiving knee treatment
Official title: Collecting Diagnostic, Treatment and Follow-up Data on Knee Treatments.
Run by UMC Utrecht · NCT04364334 · Data updated 2026-11-12
This study collects information from patients getting knee treatment at a clinic to see how their knee function, pain, and mobility change before and after treatment.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1000000 (estimated) |
| Sponsor | UMC Utrecht Academic / other |
| Locations | 1 site (Utrecht) |
| Status | Recruiting |
| Started | January 2017 |
| Main results expected | January 2100 |
| Study ends | January 2100 |
| Registry record updated | December 5, 2023 |
| Trial ID | NCT04364334 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 16 and older receiving orthopedic knee treatment at UMC Utrecht who can read and understand Dutch.
✕Probably not a fit
Patients who are receiving knee treatment elsewhere or refuse treatment will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects data on patients visiting the Mobility Clinic at the University Medical Center Utrecht for orthopedic knee treatment. It gathers patient characteristics, treatment parameters, and responses to questionnaires regarding knee function, pain, and mobility before and after treatment. The aim is to create a comprehensive database that can be utilized for future research questions related to knee pathology. The study involves all patients receiving treatment at the clinic, ensuring a broad representation of knee-related conditions.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of knee treatments and improve patient outcomes through data-driven insights.
How similar studies have gone: Other observational registries have shown success in improving treatment outcomes and understanding patient needs, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Receives orthopaedic knee surgery or conservative knee treatment (advice, physiotherapy, injections etc) at the UMC Utrecht; * Able to read and understand Dutch language; * Is able and willing to signs the broad consent form. Exclusion Criteria: * Receives no treatment (refusal of surgery or treatment); * Receives treatment elsewhere.
Where it's running
-
University Medical Center Utrecht
Utrecht, Netherlands Recruiting
Study contacts
- Principal investigator: Roel Custers, Dr — Orthopedic surgeon
- Study coordinator: Linda Kornegoor, MSc
- Email: l.kornegoor@umcutrecht.nl
- Phone: 088 75 69349
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating outcomes of knee joint surgeries using resorbable screws for osteochondral injuries
This study is testing if using special screws that dissolve can help teenagers and young adults recover better from knee surgeries for cartilage injuries.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Undenatured Type II Collagen for Knee Osteoarthritis Pain (Three-Arm Trial)
This study tests whether taking undenatured type II collagen capsules once daily for 4 months can reduce knee pain in adults with knee osteoarthritis, compared with two collagen formulations and a placebo.
-
Serum Fetuin‑A and COMP levels in knee osteoarthritis
This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.